Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1149220190270030213
Korean Journal of Oriental Medical Prescription
2019 Volume.27 No. 3 p.213 ~ p.221
A Comparative Clinical Trial to Evaluate the Efficacy and Safety of 'Hwangryunhaedok-tang' in Treatment of Gastritis : Study Protocol
Kim Hee-Yeon

Choi Jun-Yong
Cheon Jin-Hong
Kim Kyung-Ho
Kim Kwang-Youn
Oh Tae-Woo
Kim Young-Woo
Park Kwang-Il
Kim Ki-Bong
Abstract
Objectives : The purpose of this study is to confirm the efficacy and safety of the treatment of gastritis with 'Hwangryunhaedok-tang¡®.

Methods : Total 20 people, between 19 and 65 years old, will be recruited to participate in a comparative clinical trial. All subjects will take 2 capsules of Hwangryunhaedok-tang (Redoxin Cap.), 3 times a day, 30 minutes after meals, for 8 weeks. Outcomes will be measured at the baseline, 4th week, and 8th week. Primary outcomes is the improvement rates of gastritis symptoms, such as heartburn, nausea/vomiting, abdominal bloating, anorexia, heartburn, and trim.

Results : This trial was approved by institutional review board of Pusan National University Korean Medicine Hospital (registry number: 2018011), and registered in Clinical Research information Service, one of WHO. Recruitment opened in April 2019 and is supposed to be completed by December 2019.

Conclusions : This trial will provide clinical information to determine the efficacy and safety of treatment of gastritis with 'Hwangryunhaedok-tang¡®.
KEYWORD
Hwangryunhaedok-tang, gastritis, clinical trial, protocol
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)